NextCure Inc expected to post a loss of 61 cents a share - Earnings Preview

NextCure

02/08/2021 12:46

* NextCure Inc  NXTC.OQ   NXTC.O  is expected to show a no
change in quarterly revenue when it reports results on August 4
(estimated). 
​* Refinitiv's mean analyst estimate for NextCure Inc is for a
loss of 61 cents per share. For the same quarter last year, the
company reported a loss of 53 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for NextCure Inc is
$17​, about 59.2% above​ its last closing price of $6.93. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.61       -0.59      -0.60     Missed  -2.1
 Dec. 31 2020  -0.61       -0.60      -0.54     Beat    9.7
 Sep. 30 2020  -0.56       -0.57      -0.59     Missed  -4.2​
 Jun. 30 2020  -0.51       -0.50      -0.53     Missed  -5.8
 Mar.          -0.44​      -0.44      0.33      Beat    174.5​
 31​ 2020​                                              
 Dec. 31 2019  -0.46       -0.45      -0.34     Beat    25.4​
 Sep. 30 2019  -0.35       -0.35      -0.37     Missed  -5.7
 Jun. 30 2019  -0.48       -0.46      -0.61     Missed  -31.2
 This summary was machine generated August 2 at 11:46 GMT.  All
figures in US dollars unless otherwise stated